Income-oriented investors often consider business development companies because these entities raise funds to provide direct loans to U.S. middle-market businesses and distribute the majority of earnings as dividends. In this category, ARCC (Ares Capital Corporation) and GBDC (Golub Capital BDC) rank among the more closely watched names, each delivering yields near or above 10 percent. This comparison looks at differences in scale, credit quality, performance, and positioning—elements that influence decisions for both retail investors seeking income and institutional participants focused on momentum and risk.
ARCC stands as the largest publicly traded BDC, with a market capitalization of approximately $13 billion and a broad portfolio spanning software, healthcare, and business services. The stock has recently traded in the lower-middle portion of its 52-week range and sits below both its 50- and 200-day moving averages, indicating some near-term softness in momentum. I also checked this using Tickeron’s AI Trend Prediction Engine to gauge the broader context. On the fundamentals side, non-accrual loans have improved to roughly 1.8 percent of the portfolio at cost, and NAV per share has reached a record high. The company recently announced an agreement to acquire MidCap Financial Investment Corporation, which would expand its lending reach. With a quarterly dividend of $0.48 per share and a yield above 10 percent, ARCC continues to carry a “strong buy” analyst consensus and an average price target that suggests potential upside.
GBDC focuses on senior secured and one-stop loans to U.S. middle-market companies, many backed by private equity sponsors. Its market capitalization stands near $3.2 billion, making it notably smaller than ARCC, while the dividend yield remains in the 10-to-11 percent range. Recent quarterly results showed net investment income slightly below the prior period, and NAV per share declined, reflecting valuation pressure. The elevated payout ratio has also drawn notice because it exceeds levels generally viewed as sustainable. Some analysts have lowered price targets, and insider activity has tilted toward selling. These elements have contributed to softer relative performance and momentum for GBDC lately.
Although both entities operate as BDCs, they differ in important ways. ARCC’s market capitalization is roughly four times that of GBDC, supporting wider diversification and better access to capital that can help absorb isolated credit issues. GBDC runs a more concentrated portfolio of senior secured and one-stop loans, leaving it more exposed to individual credit outcomes due to its smaller size. Both stocks trade near or below book value, with ARCC close to parity and GBDC at a discount. Growth paths also vary: ARCC is pursuing expansion via acquisition, while GBDC integrates earlier deals amid a higher payout load. On the risk side, GBDC’s falling NAV and elevated payout stand out, whereas ARCC’s improving non-accrual trend and record NAV suggest more stable credit conditions overall.
Considering observable elements such as trend consistency, credit quality, NAV stability, and relative momentum, Tickeron’s AI framework currently favors ARCC over GBDC. The larger scale, record NAV, improving non-accrual metrics, and announced growth move give ARCC a steadier profile, while GBDC’s declining NAV and higher payout ratio add more uncertainty. This remains a probabilistic view rather than a fixed conclusion, and relative standing can change with evolving market conditions.
When I evaluate automated approaches for holdings like these, Tickeron’s AI Trading Bots offer a practical way to review hundreds of data-driven strategies and identify those aligned with current conditions. The platform highlights bots whose performance and parameters suit prevailing market environments, covering a range of styles from short-term momentum to longer-term trend following. This resource helps me quickly assess which systematic tools might complement analysis of names such as ARCC and GBDC.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
GBDC moved below its 50-day moving average on November 16, 2026 date and that indicates a change from an upward trend to a downward trend. In 30 of 61 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 49%.
The 10-day RSI Indicator for GBDC moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In 10 of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at 26%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GBDC as a result. In 38 of 104 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 37%.
The Moving Average Convergence Divergence Histogram (MACD) for GBDC turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 20 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 38%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GBDC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 31%.
The Aroon Indicator for GBDC entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 22 of 55 cases where GBDC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 40%.
The 10-day moving average for GBDC crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 4 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 22%.
Following a +1.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where GBDC advanced for three days, in 105 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 34%.
GBDC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 17 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 34 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. GBDC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.893) is normal, around the industry mean (2.423). P/E Ratio (19.303) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.318). Dividend Yield (0.104) settles around the average of (0.274) among similar stocks. P/S Ratio (16.129) is also within normal values, averaging (15.906).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an private equity fund
Industry InvestmentManagers